Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of a genomic test (MammaPrint™) in daily clinical practice to assist in risk stratification of young breast cancer patients

11 Apr 2010

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Breast Cancer Treatment Studies
Share to Breast Lesions and Carcinomas

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 20383789
DOI: 10.1007/s00404-010-1454-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of a genomic test (MammaPrint™) in daily clinical practice to assist in risk stratification of young breast cancer patientsPMID 20383789Read ↗

Clinical genetics in breast cancer.Semantic proximity Read ↗

Breast cancer genetics and risk assessment 101: What women's health care providers need to know.Semantic proximity Read ↗

Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and GermanySemantic proximity Read ↗

Genetic tests to identify risk for breast cancer.Semantic proximity Read ↗

A practical guide to interpretation and clinical application of personal genomic screening.Semantic proximity Read ↗

Update: variable implementation of the 2018 UKCGG/UKGTN guidelines for breast cancer gene panel tests offered by UK genetics services.Semantic proximity Read ↗

EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer.Semantic proximity Read ↗

Summaries for patients. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: U.S. Preventive Services Task Force recommendations.Semantic proximity Read ↗

Clinical utility and future of genetic profiles for breast cancerSemantic proximity Read ↗

[Genomic biomarker].Semantic proximity Read ↗

Universal genetic testing of patients with newly diagnosed breast cancer - ready for prime time?Semantic proximity Read ↗

What genetic testing can tell you about breast cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.